Search research articles
Contact Us
Filters
Showing results (411-420 of 434) with videos related to
Page
of 44
Sort By:
Clinical Pharmacology and Therapeutics
|
April 9, 2010
Integration of genetic, clinical, and INR data to refine warfarin dosing
P Lenzini, M Wadelius, S Kimmel, et al.
JCO Clinical Cancer Informatics
|
December 17, 2024
Implementing Cancer Registry Data With the PCORnet Common Data Model: The Greater Plains Collaborative Experience
Bradley D McDowell, Michael A O'Rorke, Mary C Schroeder, et al.
Medrxiv : the Preprint Server for Health Sciences
|
October 7, 2024
Pediatric Long COVID Subphenotypes: An EHR-based study from the RECOVER program
Vitaly Lorman, L Charles Bailey, Xing Song, et al.
Journal of the National Cancer Institute
|
November 23, 2013
Predicting degree of benefit from adjuvant trastuzumab in NSABP trial B-31
Katherine L Pogue-Geile, Chungyeul Kim, Jong-Hyeon Jeong, et al.
Nature
|
December 22, 2006
No supernovae associated with two long-duration gamma-ray bursts
Johan P U Fynbo, Darach Watson, Christina C Thöne, et al.
Thrombosis and Haemostasis
|
December 22, 2011
Pharmacogenetic warfarin dose refinements remain significantly influenced by genetic factors after one week of therapy
Benjamin D Horne, Petra A Lenzini, Mia Wadelius, et al.
Medrxiv : the Preprint Server for Health Sciences
|
February 20, 2025
Vaccine Effectiveness Among 5- to 17-year-old Individuals with Prior SARS-CoV-2 Infection: An EHR-Based Target Trial Emulation Study from the RECOVER Project
Jiajie Chen, Yuqing Lei, Qiong Wu, et al.
Lancet (London, England)
|
January 18, 2011
Identification of ADAMTS7 as a novel locus for coronary atherosclerosis and association of ABO with myocardial infarction in the presence of coronary atherosclerosis: two genome-wide association studies
Muredach P Reilly, Mingyao Li, Jing He, et al.
Nature Communications
|
April 17, 2026
Target Trial Emulation of Vaccine Effectiveness in 5- to 17-years-olds with Prior SARS-CoV-2 Infection
Yuqing Lei, Jiajie Chen, Qiong Wu, et al.
Clinical Pharmacology and Therapeutics
|
November 8, 2012
Impact of the CYP4F2 p.V433M polymorphism on coumarin dose requirement: systematic review and meta-analysis
E Danese, M Montagnana, J A Johnson, et al.
Page
of 44
Search research articles
Search
Showing results (411-420 of 434) with videos related to
Sort By:
Page
of 44
Clinical Pharmacology and Therapeutics
|
April 9, 2010
Integration of genetic, clinical, and INR data to refine warfarin dosing
P Lenzini, M Wadelius, S Kimmel, et al.
JCO Clinical Cancer Informatics
|
December 17, 2024
Implementing Cancer Registry Data With the PCORnet Common Data Model: The Greater Plains Collaborative Experience
Bradley D McDowell, Michael A O'Rorke, Mary C Schroeder, et al.
Medrxiv : the Preprint Server for Health Sciences
|
October 7, 2024
Pediatric Long COVID Subphenotypes: An EHR-based study from the RECOVER program
Vitaly Lorman, L Charles Bailey, Xing Song, et al.
Journal of the National Cancer Institute
|
November 23, 2013
Predicting degree of benefit from adjuvant trastuzumab in NSABP trial B-31
Katherine L Pogue-Geile, Chungyeul Kim, Jong-Hyeon Jeong, et al.
Nature
|
December 22, 2006
No supernovae associated with two long-duration gamma-ray bursts
Johan P U Fynbo, Darach Watson, Christina C Thöne, et al.
Thrombosis and Haemostasis
|
December 22, 2011
Pharmacogenetic warfarin dose refinements remain significantly influenced by genetic factors after one week of therapy
Benjamin D Horne, Petra A Lenzini, Mia Wadelius, et al.
Medrxiv : the Preprint Server for Health Sciences
|
February 20, 2025
Vaccine Effectiveness Among 5- to 17-year-old Individuals with Prior SARS-CoV-2 Infection: An EHR-Based Target Trial Emulation Study from the RECOVER Project
Jiajie Chen, Yuqing Lei, Qiong Wu, et al.
Lancet (London, England)
|
January 18, 2011
Identification of ADAMTS7 as a novel locus for coronary atherosclerosis and association of ABO with myocardial infarction in the presence of coronary atherosclerosis: two genome-wide association studies
Muredach P Reilly, Mingyao Li, Jing He, et al.
Nature Communications
|
April 17, 2026
Target Trial Emulation of Vaccine Effectiveness in 5- to 17-years-olds with Prior SARS-CoV-2 Infection
Yuqing Lei, Jiajie Chen, Qiong Wu, et al.
Clinical Pharmacology and Therapeutics
|
November 8, 2012
Impact of the CYP4F2 p.V433M polymorphism on coumarin dose requirement: systematic review and meta-analysis
E Danese, M Montagnana, J A Johnson, et al.
Page
of 44